Clinical Outcomes and Biological Correlates of Eribulin Plus Pembrolizumab Therapy for Metastatic Soft Tissue Sarcomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates
Clin. Cancer Res 2024 Jan 18;[EPub Ahead of Print], CL Haddox, MJ Nathenson, E Mazzola, JR Lin, J Baginska, A Nau, JL Weirather, E Choy, A Marino-Enriquez, JA Morgan, GM Cote, P Merriam, AJ Wagner, PK Sorger, S Santagata, S GeorgeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.